Evidence map›Paper›PMID 29212046›Full record

ArticleStem cell research2018

Hematopoietic defects in response to reduced Arhgap21.

Juliana Xavier-Ferrucio, Lauremília Ricon, Karla Vieira, Ana Leda Longhini, Mariana Lazarini, Carolina Louzão Bigarella, Gilberto Franchi, Diane S Krause, Sara T O Saad

Open access · goldAbstract read
In one paragraph

Article in Stem cell research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Role of Rho GTPases in stem cell regulation.Biochemical Society transactions · 2021
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Juliana Xavier-FerrucioHematology and Blood Transfusion Center University of Campinas/Hemocentro-UNICAMP, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, SP, Brazil; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA.; Yale Stem Cell Center, Yale School of Medicine, New Haven, CT, USA.
Lauremília RiconHematology and Blood Transfusion Center University of Campinas/Hemocentro-UNICAMP, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, SP, Brazil.
Karla VieiraHematology and Blood Transfusion Center University of Campinas/Hemocentro-UNICAMP, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, SP, Brazil.
Ana Leda LonghiniHematology and Blood Transfusion Center University of Campinas/Hemocentro-UNICAMP, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, SP, Brazil.
Mariana LazariniHematology and Blood Transfusion Center University of Campinas/Hemocentro-UNICAMP, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, SP, Brazil; Department of Biological Sciences, Federal University of São Paulo, Diadema, Brazil.
Carolina Louzão BigarellaHematology and Blood Transfusion Center University of Campinas/Hemocentro-UNICAMP, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, SP, Brazil.
Gilberto FranchiOnco-Hematological Child Research Center (CIPOI), Faculty of Medical Sciences, University of Campinas-UNICAMP, Campinas, SP, Brazil.
Diane S KrauseDepartment of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA.; Yale Stem Cell Center, Yale School of Medicine, New Haven, CT, USA.
Sara T O SaadHematology and Blood Transfusion Center University of Campinas/Hemocentro-UNICAMP, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, SP, Brazil. Electronic address: sara@unicamp.br.
Universidade Estadual de Campinas (UNICAMP) · BRYale Cancer Center · US

Funding

Yale Cooperative Hematology Specialized Core CenterU54DK106857 · NIDDK · YALE UNIVERSITY · PI JOHN HWA, Diane S Krause · 2015 to 2026
$9.7M
Mechanisms of megakaryocyte maturationR01DK094934 · NIDDK · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2012 to 2016
$2.7M
Megakaryocyte erythroid progenitor fate specificationR01DK114031 · NIDDK · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2017 to 2020
$2.2M
MKL in megakaryocytopoiesisR01DK086267 · NIDDK · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2010 to 2013
$1.5M
NIDDK NIH HHS R01 DK086267NIDDK NIH HHS R01 DK094934NIDDK NIH HHS R01 DK114031NIDDK NIH HHS U54 DK106857
6 · The paper itself

Abstract

Arhgap21 is a member of the Rho GTPase activating protein (RhoGAP) family, which function as negative regulators of Rho GTPases. Arhgap21 has been implicated in adhesion and migration of cancer cells. However, the role of Arhgap21 has never been investigated in hematopoietic cells. Herein, we evaluated functional aspects of hematopoietic stem and progenitor cells (HSPC) using a haploinsufficient (Arhgap21

Indexed as

HaploinsufficiencyAnimalsBone Marrow CellsCell DifferentiationCell MovementCell ProliferationCells, CulturedErythroid CellsFibronectinsGTPase-Activating ProteinsHematopoiesisHematopoietic Stem CellsHumansMiceMice, Inbred C57BLMice, KnockoutARHGAP21 protein, humanFibronectinsGTPase-Activating ProteinsrhoC GTP-Binding ProteinArhgap21Erythroid cellsFate decisionHematopoiesisHematopoietic stem and progenitor cells

Identifiers

PMID29212046
PMCPMC6084430
OpenAlexW2770174011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.